ICON plc is a global contract research organization (CRO) specializing in the delivery of comprehensive drug development solutions to the pharmaceutical, biotechnology and medical device industries. Founded in 1990 and headquartered in Dublin, Ireland, the company provides a broad suite of services spanning clinical trial design, execution and management. By integrating scientific expertise with advanced data analytics and technology platforms, ICON supports its clients in bringing new therapies and medical products to market efficiently and in compliance with regulatory standards.
The company’s core offerings include clinical development services such as protocol design, patient recruitment and site management, safety and pharmacovigilance, biostatistics and data management. ICON also delivers specialized consulting solutions covering regulatory strategy, market access and health economics. Additionally, its real-world evidence and outcomes research capabilities draw on extensive patient data to inform product development decisions and optimize commercial strategies.
ICON operates in more than 50 countries with a network of regional offices across North America, Europe, Asia Pacific and Latin America. This global footprint enables the company to manage multi-site, multinational studies and to engage diverse patient populations. Over the years, ICON has expanded its reach and service portfolio through strategic acquisitions, most notably the integration of PRA Health Sciences in 2021, bolstering its capacity in late-stage clinical development and operational scale.
Originally established by John Climax, ICON has grown into one of the leading independent CROs under the leadership of Chief Executive Officer Peter Gray. The company’s senior management team combines deep industry experience with a commitment to innovation, quality and patient safety. As a publicly traded entity on the NASDAQ under the symbol ICLR, ICON remains focused on advancing clinical research through a client-centric approach and cutting-edge technological solutions.
AI Generated. May Contain Errors.
